cycloheximide has been researched along with Mesothelioma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbone, D; Broaddus, VC; Bueno, R; Gordon, GJ; Jablons, DM; Nishimura, SL; Sugarbaker, DJ; Wilson, SM; Yang, TM | 1 |
Betta, PG; Biffo, S; Grosso, S; Patrone, M; Ranzato, E; Viarengo, A | 1 |
Bhandary, YP; Florova, G; Idell, S; Koenig, K; Marudamuthu, AS; Shetty, P; Shetty, RS; Shetty, S; Shetty, SK; Tucker, T; Velusamy, T | 1 |
Abayasiriwardana, KS; Broaddus, VC; Collins, R; Fjellbirkeland, L; Jablons, DM; Kim, KU; Nishimura, SL; Wilson, SM; Xu, Z | 1 |
Abayasiriwardana, KS; Barbone, D; Broaddus, VC; Dansen, TB; Evan, GI; Hunt, AE; Kim, KU; Lee, KK; Vivo, C | 1 |
Idell, S; Kumar, A; Shetty, S | 1 |
Idell, S; Shetty, S | 1 |
Catalano, A; Martinotti, S; Procopio, A; Romano, M | 1 |
Idell, S; Johnson, AR; Koenig, KB; Kumar, A; Zwieb, C | 1 |
9 other study(ies) available for cycloheximide and Mesothelioma
Article | Year |
---|---|
mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids.
Topics: Cell Line, Tumor; Cell Survival; Chromones; Cycloheximide; Deoxycytidine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gemcitabine; Humans; Mesothelioma; Morpholines; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; RNA, Small Interfering; Signal Transduction; Sirolimus; Spheroids, Cellular; TNF-Related Apoptosis-Inducing Ligand; TOR Serine-Threonine Kinases | 2008 |
Spreading of mesothelioma cells is rapamycin-sensitive and requires continuing translation.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Culture Media, Serum-Free; Cycloheximide; Fibronectins; Humans; Lung Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mesothelioma; Multiprotein Complexes; Neoplasm Metastasis; Protein Biosynthesis; Protein Synthesis Inhibitors; Proteins; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors | 2009 |
Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.
Topics: Blotting, Northern; Blotting, Western; Carcinogens; Cells, Cultured; Cycloheximide; Epithelium; Gene Expression Regulation; Humans; Mesothelioma; Plasminogen Activator Inhibitor 1; Pleura; Pleural Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transforming Growth Factor beta | 2010 |
A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Chromones; Class I Phosphatidylinositol 3-Kinases; Collagen; Cycloheximide; Humans; In Vitro Techniques; Macrophages; Membrane Glycoproteins; Mesothelioma; Models, Biological; Morpholines; Phosphatidylinositol 3-Kinases; Protein Kinases; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Signal Transduction; Spheroids, Cellular; Stromal Cells; TNF-Related Apoptosis-Inducing Ligand; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2005 |
Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim.
Topics: Anisomycin; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Combined Modality Therapy; Cycloheximide; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Etoposide; Humans; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Ligands; Membrane Proteins; Mesothelioma; Phosphorylation; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2007 |
Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
Topics: Base Sequence; Binding Sites; Cycloheximide; Dactinomycin; Epithelial Cells; Epithelium; Gene Expression; Globins; Humans; Lipopolysaccharides; Mesothelioma; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Pleural Neoplasms; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; RNA; RNA-Binding Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 1997 |
Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.
Topics: Anisomycin; Carcinoma; Cell Movement; Cycloheximide; DNA; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mesothelioma; Pleura; Protein Biosynthesis; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; RNA Processing, Post-Transcriptional; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1999 |
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
Topics: Angiogenesis Inducing Agents; Antigens, Polyomavirus Transforming; Cycloheximide; Endothelial Growth Factors; Gene Expression Regulation; Humans; Lymphokines; Mesothelioma; Phosphorylation; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2002 |
Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
Topics: Base Sequence; Blood Coagulation Factors; Cells, Cultured; Cycloheximide; Dactinomycin; Epithelium; Fibrin; Fibrinolysis; Fibroblasts; Humans; Inflammation; Lung; Mesothelioma; Molecular Sequence Data; Oligonucleotide Probes; Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Pleural Effusion; Prothrombin; RNA, Messenger; Tissue Plasminogen Activator; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 1992 |